INSP
Inspire Medical Systems Inc
NYSE: INSP · HEALTHCARE · MEDICAL DEVICES
$51.07
-1.73% today
Updated 2026-07-29
Market cap
$1.53B
P/E ratio
11.51
P/S ratio
1.68x
EPS (TTM)
$4.63
Dividend yield
—
52W range
$39 – $147
Volume
1.0M
Inspire Medical Systems Inc (INSP) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$51.07
12-Month target
$53.68
2030 Target
—
Intrinsic (DCF)
$449.81
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.4B | $0.6B | $0.8B | $0.9B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 11.51x (capped 25x) · Margin: 14.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.